Atlas Trials

COX-2 Inhibitor to Prevent Post-ERCP Pancreatitis

Clinical trial NCT02964403 · UNKNOWN

Trial details

NCT number
NCT02964403
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Pancreatitis, Acute
Start date
2016-12-01
Primary completion
2018-02-01
Enrollment
2700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.